Muscle mass change after BoNT-A injection in cerebral palsy
Not Applicable
Completed
- Conditions
- Diseases of the nervous system
- Registration Number
- KCT0004591
- Lead Sponsor
- The Catholic University of Korea, Incheon St. Mary's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
1. Spastic hemiplegic cerebral palsy
2. age between 2-18 years
Exclusion Criteria
1. those who had an allergic reaction to BoNT-A;
2. those who, at screening, were participating in other clinical trials or were taking muscle relaxants, benzodiazepine, or anticholinergic drugs within four weeks of screening
3. those who had received a botulinum toxin injection within the previous six months
4. those who had been treated with intrathecal baclofen, selective dorsal rhizotomy, or other orthopedic surgery.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The ratio of lean body mass of injected leg to non-injected leg after botulinum toxin injection
- Secondary Outcome Measures
Name Time Method The ratio of lean body mass of injected leg or non-injected leg to total body after botulinum toxin injection